Price: $97.82
· 1 day: +1.52% · 5 days: -18.01% · 1 month: -41.22%
As of 2026-11-03 21:00 UTC.
52-week range: $95.03 – $386.34 (currently at 1% of the range).
CBRS is in a range / mixed, momentum soft. $100 is the level overhead; $96.36 the first support below.
4 of 4 technical checks lean bearish.
| Trend | Range / mixed · below 50-day |
|---|---|
| Momentum | RSI 22.3 · neutral · MACD bearish |
| Trend strength | ADX 36.6 · strong trend |
| Location | -40.7% vs 50-day MA |
| 52-week range | -69% from high · +2% from low |
| Volatility | ATR 10.21 · ~10.4%/day |
| Level | Type | Distance |
|---|---|---|
| $100.0 (resistance) | round | 2.23% |
| $110.0 (resistance) | round | 12.45% |
| $165.07 (resistance) | sma 50 | 68.75% |
| $96.36 (support) | 52w low | -1.49% |
| $90.0 (support) | round | -7.99% |
| $80.0 (support) | round | -18.22% |
| RSI (14) | 22.3 | MACD | -19.9483 |
|---|---|---|---|
| ADX (14) | 36.6 | ATR (14) | 10.21 |
| 50-day average | $165.07 | 200-day average |
Next earnings: 2026-11-12. CBRS earnings date, time and past reactions.
Report of 2026-10-28, updated 2026-11-02.
Cerebras Systems (CBRS) has fallen another 7.2% on November 2, bringing the five-day decline to 6.5%, as the stock continues to slide following Intel's weak guidance and a short-seller report from Culper Research alleging wafer-scale processor failures within 1.5–2.5 years (The Motley Fool). The stock now sits at $101.31, down 48% from its September 29 peak and at a new 52-week low, while SOXX fell 3.4% over the same five days and SPY dropped 0.6%.
The picture holds. The daily trend remains aligned with the weekly downtrend, and the stock is still below its 40-week average. The key downside breakout level from the assessment—a daily close below $100.00 (round)—is now just 1.3% away, with the next support at $75.00. Resistance has moved lower: the stock is now trading below the $125.00 round level where sellers previously emerged, and the 50-day SMA has dropped to $166.92. What would change the picture is a weekly close above $168.71 (swing zone), which remains far above the current price.
Relative weakness persists, with CBRS lagging SPY by 38.8% and SOXX by 31.9% over 50 days. The RSI at 20.14 signals oversold conditions, but volume is 81% below the 20-day average, suggesting limited buying interest. Earnings are due November 12, and the analyst consensus remains strong buy with a mean target of $282.55, though the stock trades 64% below that level.
Cerebras Systems (CBRS) jumped 10.1% to $119.31 in its latest session, but the bounce sits inside a 42.3% fall from the September 25, 2026 peak, and the balance of evidence still leans negative. The weekly trend is down and the daily trend runs with it. Over 50 days the stock trails the S&P 500 by 32.0% and the semiconductor ETF SOXX by 29.2%. Conviction in the negative reading is high.
No news item in the material behind this note explains what has happened to CBRS. There is no filing, company announcement or analyst action to point to for the 42.3% slide over the past month, or for the 10.1% jump that followed. The price action is therefore the main evidence, and it has to be read as price action rather than as a reaction to a story.
The stock closed at $206.75 on September 25, 2026, and the 52-week high is $311.07. At $119.31 it is 61.65% below that high and only 10.1% above the 52-week low of $108.37. The daily RSI is 18.22, deeply oversold, and the bounce came on volume 32.9% above the 20-day average. That combination is what a sharp relief rally after a hard fall usually looks like. It shows sellers paused. It does not show that buyers have taken control.
Most of the one-day move was the stock's own. SOXX rose 3.9% and SPY 0.56%, against 10.1% for CBRS. Over five days the picture is more modest: the stock is up 0.9%, SPY 0.08% and SOXX 2.21%. CBRS has lagged its sector by 1.3 points, so the four sessions before the bounce were net lower. The market contributed almost nothing, and the sector gave a small lift. The sector itself is not the problem: SOXX is up 69.7% year to date, though down 10.76% over the past month. CBRS has fallen far more than its peers.
With no articles to cite, the debate shows up in the numbers. The bullish side is the analyst community: 11 analysts with a consensus of strong buy, a mean price target of $282.55, and targets ranging from $175 to $330. The stock trades 57.8% below that mean. The bearish side is the tape, which has taken the shares to the lower end of their yearly range and kept them under every moving average that matters. Even the lowest target, $175, sits almost exactly on the 50-day average of $174.99. Price targets tend to follow price rather than lead it, so the gap to $282.55 is better read as a measure of how far sentiment has to travel than as support under the shares.
On the long term, the thesis is broken for now. The price is below its 40-week average, the stock is 61.65% under its high, and it is also below its 10-week average. The advance that took it to $311.07 has been undone, and the shares are in a decline phase that has not yet built a base. A 200-day average is not yet available to lean on, so the long-term picture rests on the weekly trend and the distance from the high.
For the next 2–6 weeks, the balance of evidence leans negative, and conviction is high at 3 of 4 points. The daily trend runs with the weekly downtrend. The stock is lagging the S&P 500 over 50 days (-32.0%), and it is lagging SOXX over the same period (-29.2%). Those are three independent pieces of evidence pointing the same way, and they agree with the position of the price under the 50-day average.
The strongest case against is the bounce itself. An RSI of 18.22 is an extreme, a 10.1% one-day gain on heavy volume can mark a low, and the shares sit just 10.1% above the 52-week low with analysts far above the price. It does not tip the balance because the stock is still below $125, where sellers have shown up on rallies, and still below the 10-week average. One strong session after a 42.3% drop has not changed the trend. It is the best argument for not treating the negative reading as certain.
The structure is down, so the level that matters is above the price. The stock sits below $125, a round number where sellers have shown up on rallies. Above it the next barriers are $150, then the $168.71 swing zone. The weekly trend would end above $174.99, the 50-day average, which is also the level that would show the damage from September has been repaired.
The breakout level on the downside is a daily close below $108.37, the 52-week low. From there the math runs to targets at $100, which is 0.4 to 1, and $75, which is 1.7 to 1, against a stop at $127.58, the $125 resistance plus a quarter of the 14-day ATR of $10.30. The math does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target well below $75, or a stop much closer to the breakout level, to get there.
A weekly close above $174.99, the 50-day average, would be the first price evidence that the downtrend has ended. The non-price fact that could produce it is the earnings report on November 12, 2026, if results and guidance give buyers a concrete reason to pay up and begin to close the gap between the price and the analyst targets.
Interactive CBRS chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs